Fortress Biotech's competitors

Fortress Biotech's competitors include Teewinot Life Sciences, BioCryst Pharmaceuticals, TiGenix and Portola Pharmaceuticals
Add company...
Fortress Biotech
Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products.
Teewinot Life Sciences
Teewinot Life Sciences Corporation is a biopharmaceutical company focused on the production and development of cannabinoid-based pharmaceuticals therapies.
BioCryst Pharmaceuticals
BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.
TiGenix
TiGenix NV is a leading European cell therapy company with an advanced clinical stage pipeline of adult stem cell programmes.
Portola Pharmaceuticals
Portola Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops therapeutics for acute and chronic cardiovascular and autoimmune/inflammatory diseases.
Founding Date
Founding Date
2006
Founding Date
2015
Founding Date
1986
Founding Date
2000
Founding Date
2003
Type
Type
Public
Type
Private
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
New York, US HQ
Locations
Tampa, US HQ
Locations
Durham, US HQ
Hoover, US
Locations
Leuven, BE HQ
Locations
South San Francisco, US HQ
Employees
Employees
45 32% increase
Employees
N/A
Employees
65 30% decrease
Employees
65
Employees
163
Valuation ($)
Valuation ($)
189 m
Valuation ($)
N/A
Valuation ($)
414.5 m
Valuation ($)
N/A
Valuation ($)
2.8 b
Facebook followers
Facebook followers
21
Facebook followers
N/A
Facebook followers
N/A
Facebook followers
112
Facebook followers
N/A
Twitter followers
Twitter followers
290
Twitter followers
123
Twitter followers
422
Twitter followers
N/A
Twitter followers
632

Financial

Revenue (est.)
Revenue (est.)
$16.5m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
$26.4m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
$790k (FY, 2016)
Cost of goods
N/A
Cost of goods
$2.3m (FY, 2016)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$15.7m (FY, 2016)
Gross profit
N/A
Gross profit
$24.1m (FY, 2016)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($71.3m) (FY, 2016)
Net income
N/A
Net income
($55.1m) (FY, 2016)
Net income
N/A
Net income
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles